Pathkey.AI Ltd, a digital health company, involves artificial intelligence (AI) to improve clinical trials and predicting outcomes for patients in Australia. The company offers TrialKey, an AI-driven clinical trial optimization and success prediction platform, that simulate and optimize trial designs. It also provides TrialGen, an AI-powered tool streamlines clinical trial design process. The company serves biopharma, MedTech, government, and healthcare organizations. The company was formerly known as Opyl Limited and changed its name to Pathkey.AI Ltd in August 2025. Pathkey.AI Ltd was incorporated in 1994 and is based in Milsons Point, Australia.
Metrics to compare | PKY | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPKYPeersSector | |
---|---|---|---|---|
P/E Ratio | −4.6x | −5.3x | 11.8x | |
PEG Ratio | −0.08 | −0.06 | 0.01 | |
Price/Book | −24.8x | 2.7x | 2.4x | |
Price / LTM Sales | 20.7x | 3.3x | 2.3x | |
Upside (Analyst Target) | - | 12.1% | 14.9% | |
Fair Value Upside | Unlock | −4.9% | 2.3% | Unlock |